Cytokines and microRNAs in SARS-CoV-2: What do we know?

Fahimeh Zamani Rarani1, Bahman Rashidi1, Mohammad Hassan Jafari Najaf Abadi2

  • 1Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

The COVID-19 cytokine storm involves specific inflammatory molecules like TNF-α, IL-1, and IL-6. Understanding these cytokines and microRNAs may lead to better treatments for severe coronavirus disease 2019.

Area of Science:

  • Immunology
  • Virology
  • Pathophysiology

Background:

  • The COVID-19 pandemic presents a significant global health challenge with limited therapeutic options.
  • Severe COVID-19 cases can lead to a dangerous 'cytokine storm,' a hyperinflammatory response causing ARDS, MODS, and mortality.
  • Key pro-inflammatory cytokines, including TNF-α, IL-1, and IL-6, show altered levels in severe COVID-19, suggesting their role in the cytokine storm.

Purpose of the Study:

  • To review the cytokines involved in SARS-CoV-2 infection.
  • To explore the potential of interferons (IFNs) and interleukins (ILs) in COVID-19 treatment.
  • To highlight the role of microRNAs in cytokine storm pathogenesis during COVID-19.

Main Methods:

  • Literature review of scientific articles and research.
  • Analysis of cytokine profiles in mild versus severe COVID-19 cases.
  • Investigation of microRNA involvement in cytokine regulation related to SARS-CoV-2.

Main Results:

  • Elevated levels of specific cytokines (TNF-α, IL-1, IL-6) are associated with severe COVID-19 and the cytokine storm.
  • Interferons and interleukins are implicated in the pathophysiology of SARS-CoV-2 infection.
  • Certain microRNAs play a role in modulating these cytokines during the COVID-19 cytokine storm.

Conclusions:

  • Understanding the cytokine storm's pathophysiology is crucial for developing effective COVID-19 treatments.
  • Targeting specific cytokines and microRNAs could offer therapeutic strategies for severe COVID-19.
  • Further research into cytokine and microRNA roles may identify novel biomarkers and treatments for COVID-19.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.7K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K